← Eichor
Study identifier: NCT05176808 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)

Condition: Autism Spectrum Disorder · Autistic Disorder · Active Autistic Disorder  ·  Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

PhaseNA
Planned participants188
Who can joinAll sexes, 18 Months to 42 Months
Healthy volunteersNo

About this study

The primary objective of this research study is to improve outcomes involving core social-communication symptoms for young children with ASD or social communication delays by increasing access to clinically validated early behavioral intervention through a telehealth parent coaching model. The investigators will test the hypothesis that telehealth-delivered Naturalistic Developmental Behavioral Intervention parent coaching (TC) is non-inferior to in-person coaching (IPC) for the treatment of core social-communication symptoms in toddlers with either a social communication delay or ASD.

This description comes directly from the study's public registry record.

Talk to the study team

Rebecca Landa, PhD  ·  443-923-7591  ·  landa@kennedykrieger.org

Rachel Reetzke, PhD  ·  443-923-7395  ·  reetzke@kennedykrieger.org

Always discuss trial participation with your own doctor first.

Locations (1)

Kennedy Krieger InstituteBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05176808